1.Clinical application of moving cupping therapy based on skin reaction observation and syndrome differentiation.
Xiao-Lan DENG ; Bo CHEN ; Ze-Lin CHEN
Chinese Acupuncture & Moxibustion 2014;34(12):1215-1216
The diagnostic evidence on clinical diseases and theoretic basis of moving cupping therapy were ex- plored in the paper. By the observation of the local reaction, such as skin appearance and color, the affected location, duration of sickness and nature of disease were judged. Different moving cupping methods were selected for different disorders. It was discovered that the property of syndromes should be recognized by the palpation on skin and muscle in the moving cupping therapy so that the pathogenesis and treating principle could be carefully determined. The moving cupping therapy is the important component of body surface therapy. Skin reaction observation and syndrome differentiation is the essential guidance of the moving cupping therapy.
Acupuncture Points
;
Acupuncture Therapy
;
Humans
;
Meridians
;
Skin
;
anatomy & histology
;
blood supply
2.Application of Chemometrics in Quantitative Characterization of Traditional Chinese Medicine
Shiyu MA ; Lan SHEN ; Yanlong HONG ; Xiao LIN ; Yi FENG
World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(12):2700-2707
With the deepening of modernization of traditional Chinese medicine (TCM), the method of quantification and standardization of TCM (i.e., quantitative characterization of TCM) has been more and more widely accepted by researchers. Chemometrics processes complicated data of TCM through applied mathematics, statistics and com-puter technology. And multivariable study was introduced into the quantitative characterization of TCM with great achievements. This article reviewed existed problems of quantitative characterization in TCM, the principles, char-acteristics, limitations, commonly used statistical methods and application conditions on quantitative characteriza-tion of TCM. With this review, a reference for further study of quantitative characterization of TCM was provided and a further research idea of combination with main methods of chemometrics was given.
3.Correlations of serum lipoprotein (a) with ischemic stroke and its etiological subtypes
Xiaoqiang LIU ; Weiduan ZHUANG ; Ruifeng WANG ; Lan LIN ; Yingxiu XIAO
International Journal of Cerebrovascular Diseases 2016;24(12):1062-1067
Objective To investigate the correlation between serum lipoprotein (a) (Lp(a)) level andischemic stroke and its etiological subtypes. Methods The consecutive inpatients with acute ischemic stroke (case group) and age-and sex-matched healthy subjects (control group) over the same period were enrolled retrospectively. The demographic and baseline clinical data, as well as fasting blood glucose, fibrinogen,homocysteine, total cholesterol, triacylglycerol, high-densitylipoprotein cholesterol, low -density lipoprotein cholesterol, and Lp(a) concentration of the case group and the control group were collected. According to TOAST classification criteria, the patients in the case group were divided into large artery atherosclerosis (LAA), small artery occlusion (SAO) and cardioembolism (CE), and the patients with other determined etiology and undetermined etiology were excluded. Multivariate logistic regression analysis was used to make clear the correlation between serum Lp(a) and acute ischemic stroke and its etiological subtypes. Results A total of 214 patients with ischemic stroke were enrolled. Ninety-seven had LAA (45.33%), 64 (29.91%) had SAO, and 53 (24.77%) had CE. There were 118 subjects in the control group. There were significant differences in the proportions of hypertension, diabetes, hyperlipidemia, atrial fibrillation and alcohol consumption, as well as systolic blood pressure, diastolic blood pressure, fasting blood glucose, total cholesterol, low -density lipoprotein cholesterol, Lp(a), fibrinogen, and homocysteine between the case group and the control group (all P <0.001). Multivariate logistic regression analysis showed that after adjustment for age and sex, Lp(a) is an independent risk factor for ischemic stroke (odds ratio [OR] 2.014, 95% confidence interval [CI ] 1.273-3.092, P = 0.036). The independent risk factors for LAA included hypertension (OR 3.353, 95% CI 1.714-6.558, P = 0.001), systolic blood pressure ( OR 2.786, 95% CI 1.136-5.538, P =0.016), homocysteine ( OR 1.108, 95% CI 1.031-2.191, P = 0.005), total cholesterol (OR 2.169, 95% CI 1.599-4.943, P = 0.001), low -density lipoprotein cholesterol ( OR2.782, 95% CI 1.093-5.238, P =0.024), and Lp(a) (OR 3.072, 95% CI 1.907-8.064, P =0.001). Theindependent risk factors for SAO included hypertension ( OR 7.042, 95% CI 3.189-25.55, P =0.001), diabetes mellitus (OR 5.162, 95% CI 2.372-11.23, P =0.001), fibrinogen (OR 1.667, 95% CI 1.434-2.025, P = 0.045), and homocysteine (OR 1.967, 95% CI 1.859-1.995, P =0.036). The independent risk factors for CE included atrial fibrillation (OR 13.340, 95% CI 4.637-39.20, P = 0.001), fibrinogen (OR 2.365, 95% CI 1.147- 4.904, P =0.029), and Lp(a) (OR 1.656, 95% CI 1.996-3.001, P = 0.035). Conclusions Lp(a) is an independent risk factor for ischemic stroke, and can be used as a serum biomarker for predicting the risk of the onset of ischemic stroke. There are differences in independent risk factors between the different stroke etiological subtypes. Lp(a) is independently associated with LAA and CE; however, it has no independent correlation with SAO.
4.Mechanisms and strategies for targeting drugs to myocardial ischemic regions.
Acta Pharmaceutica Sinica 2010;45(7):827-832
The ischemic heart disease has been endangering human health seriously. Although there are many kinds of anti-ischemic drugs, most of them are lacking in tissue specificity, which together with a remarkably reduced blood circulation in the ischemic zone often lead to a quite low drug distribution in the targets. Myocardial ischemia can cause a lot of pathophysiological changes, such as the enhanced permeability of the endothelial cell membrane, the up-regulated expression of various cell adhesion molecules on endothelium, the exposure of intracellular antigenic components, the decrease of pH within the ischemic zone, and so on. To date, some of these changes have been exploited with limited success to gain the passive, active and physicochemical targeting of diagnostic or therapeutic drugs to myocardial ischemic regions. However, more effective delivery strategies are still eagerly needed. Here, we reviewed and discussed the potential targeting-delivery mechanisms and strategies, used or may be used in the future, for myocardial ischemic regions.
Animals
;
Antibodies, Monoclonal
;
immunology
;
Capillary Permeability
;
Drug Carriers
;
Drug Delivery Systems
;
methods
;
Genetic Therapy
;
Humans
;
Liposomes
;
chemistry
;
metabolism
;
Myocardial Ischemia
;
therapy
;
Myocardium
;
metabolism
;
pathology
;
Polyethylene Glycols
;
metabolism
;
Ultrasonics
5.Ophiopogon samponin Ⅵ?Release rate of ophiopogon saponin enteric microsphere
Lan SHEN ; Yi FENG ; Desheng XU ; Xiao LIN
Chinese Traditional Patent Medicine 1992;0(02):-
AIM: To explore the influencing factors in the release rate and give the application to the preparation. METHODS: Preparing ophiopogon saponin enteric microsphere by spray drying process,the accumulative release rate of acid and buffer solution were detected by colorimetric analysis. RESULTS: With the increase of Eudragit Ⅱ concentraction,the accumulative release rate tended to decrease.But ratio of drug and Eudragit Ⅱ,increased with the decrease in delay time on the break point. CONCLUSION: The concentration of Eudragit and the ratio of drug and material are the rey factors in the accumulative release rate in acid and buffer solution.
6.Prescription design of Ophiopogon japonicus saponin enteric microsphere by spray drying technique
Lan SHEN ; Yi FENG ; Desheng XU ; Xiao LIN
Chinese Traditional and Herbal Drugs 1994;0(03):-
Objective To explore the prescription factor on Ophiopogon japonicus saponin enteric microsphere by spray drying technique. Methods Observing the type and content of enteric coating material, the type of plasticizer, the type and dosage of antistickiness material by single factor. Optimizing the prescription by orthogonal test design. Results Both Eudragit Ⅱ and micronization silica gel made in China could meet the need of the preparation. The best prescription included the proportion between drug and enteric coating material (1∶4), the dosage of castor oil (1%), and the dosage of micronization silica gel (1.5%). Conclusion O. japonicus saponin enteric microsphere accorded with the expecting demand. The kind of medical subsidiary material made in China will be the main raw material in producing the enteric microsphere. The study of prescription design will provide the basis for realizing microencap-sulation in Chinese materia medica.
7.Effects of Tanggankang Capsule on Sugar fat Metabolizability and Liver Trauma of Diabetic Mice,Qianqiuhai,Lin Lan.
Yuexing XIAO ; Qing NI ; Qiuhai QIAN ; Lan LIN
Journal of Medical Research 2006;0(02):-
Objective To study the effect of Tanggankang capsule treating liver trauma of diabetic mice.Methods Healthy Wistar rats are used in this trial. STZ are injected into the mice’s trail vein and they are fed with feed stuff with high quantity of heat. Eight weeks later, rats with blood sugar≥11.1mmol and disturbance of lipid metabolism are selected as diabetic model. 50 rats were randomly divided into five groups:low,moderate and high dosage groups;Metformin Hydrochloride and Glucurolactone control group。Every rat is given equal dosage by mouth once a day.After 6 weeks and 12 weeks, measure the blood sugar and lipid. At the 12th weeks, rats are sacrificed to weigh the liver and compute the liver coefficient and measure TC,LPO,ALT and AST. Results Tanggankang capsule has good therapeutic effect on treating hyperglycemia and disturbance of lipid metabolism for diabetic model; Tanggankang capsule can effectively prevent from the pathological change of diabetic fatty liver;what’s more,the more dosage and longer duration of drug,the stronger effect will appear,and the effect of large dosage is better than that of control group,thus the difference is remarkable (P
8.Pharmacokinetics of Paeonia lacliflora and Glycyrrhiza uralensis Compound
Lan SHEN ; Liang ZHANG ; Yi FENG ; Desheng XU ; Xiao LIN
Chinese Traditional Patent Medicine 1992;0(03):-
AIM: To study compatibility rationality of combination of Paeonia lacliflora and Glycyrrhiza uralensis. METHODS: The effective combination of paeoniflorin(44% purity),glycyrrhizic acid(50% purity) and liquorice flavones(52% purity),glycyrrhizic acid(50% purity) and liquorice flavones(52% purity) were respectively administered to rats.Pharmacokinetic change of these constituents in rat blood was studied. RESULTS: The pharmacokinetic parameters of these constituents in rat blood showed that the increases in AUC and C_(max) of effective combination group were more than that of glycyrrhizic acid group or that of liquorice flavones group.T_(max) of the former was extended with respect to the latters.Clearance of effective combination markedly slowed down. CONCLUSION: The effective combination of paeonia lacliflora and Glycyrrhiza uralensis have the advantage of either Paeonia lacliflora or Glycyrrhiza uralensis.
9.Hallervorden-Spatz disease of childhood onset type, a report of 2 cases.
Kang WANG ; Xiao-su YANG ; Ling LI ; Lin ZHOU ; Lan XIAO ; Bo XIAO
Chinese Journal of Pediatrics 2005;43(2):151-152
10.DNCB induces colitis and its relation with LMIF activity
Ping LIN ; Lan XIAO ; Ting ZHOU ; Jingjing YANG ; Hui PAN ; Yusun JIN ; Encong GONG ; Lin MEI
Chinese Journal of Pathophysiology 2000;0(10):-
AIM: In order to explore the pathogenesis of ulcerative colitis (UC), an experimental colitis in mouse was induced by the hapten dinitrochlorobenzene (DNCB), and the activity of leukocyte migration inhibitory factor (LMIF) was measured at the same time. METHODS: 67 BALB/c mice were randomly divided into control (60% ethanol) and DNCB groups. After they were sensitized by smearing 3.3% DNCB on the abdominal skin, they were challenged with DNCB at concentration of 0.1%, 0.2% and 0.4% respectively by instillation once a day. The weight, stool viscosity and hematochezia were observed and accumulated as disease active index (DAI) score. The pathological changes in colon tissue were judged macropathologically and by means of microscope. LMIF activity was determined by the absorbance (A) of migrated leukocytes. RESULTS: Compared to control group, the increases in DAI accumulate score, pathologic score, and LMIF activity in DNCB groups were observed. CONCLUSION: Mouse colitis was induced by DNCB, which was accompanied by an increase in LMIF activity. [